Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings
AUM
$28.4B
1-Year Return
37.22%
This Quarter Return
+8.14%
1 Year Return
+37.22%
3 Year Return
+93.7%
5 Year Return
+199.54%
10 Year Return
+398.51%
AUM
$17.4B
AUM Growth
+$2.11B
(+14%)
Cap. Flow
+$1.19B
Cap. Flow
% of AUM
6.82%
Top 10 Holdings %
Top 10 Hldgs %
29.6%
Holding
1,504
New
416
Increased
423
Reduced
335
Closed
326
Top Buys
| 1 |
Apple
AAPL
|
+$114M |
| 2 |
Johnson & Johnson
JNJ
|
+$112M |
| 3 |
Walt Disney
DIS
|
+$86.7M |
| 4 |
Coca-Cola
KO
|
+$83.6M |
| 5 |
Tesla
TSLA
|
+$69.2M |
Top Sells
| 1 |
Nutrien
NTR
|
+$63.5M |
| 2 |
Brookfield Infrastructure Partners
BIP
|
+$63.2M |
| 3 |
AUY
Yamana Gold, Inc.
AUY
|
+$52.7M |
| 4 |
BP
BP
|
+$52.6M |
| 5 |
Charles Schwab
SCHW
|
+$50.3M |
Sector Composition
| 1 | Financials | 24.15% |
| 2 | Industrials | 13.69% |
| 3 | Energy | 13.35% |
| 4 | Technology | 11.88% |
| 5 | Materials | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOHU
726
Sohu.com
SOHU
$480M
| $919K | 0.01% |
67,041
-6,605
| -9% | -$90.6K |
|
727
Altice USA
ATUS
$1.12B
| $915K | 0.01% |
198,906
+42,113
| +27% | +$194K |
|
728
10x Genomics
TXG
$1.59B
| $914K | 0.01% |
+25,085
| New | +$914K |
|
729
Cintas
CTAS
$82.1B
| $914K | 0.01% |
8,092
-83,504
| -91% | -$9.43M |
|
730
Health Catalyst
HCAT
$232M
| $902K | 0.01% |
84,876
-56,450
| -40% | -$600K |
|
731
RenaissanceRe
RNR
$11.3B
| $899K | 0.01% |
+4,881
| New | +$899K |
|
732
Quest Diagnostics
DGX
$20.4B
| $898K | 0.01% |
5,738
-68
| -1% | -$10.6K |
|
733
Principal Financial Group
PFG
$18.1B
| $890K | 0.01% |
10,608
-4,124
| -28% | -$346K |
|
734
The Mosaic Company
MOS
$10.7B
| $887K | 0.01% |
20,228
-17,779
| -47% | -$780K |
|
735
Vertiv
VRT
$51.8B
| $887K | 0.01% |
64,898
-206,361
| -76% | -$2.82M |
|
736
Commercial Vehicle Group
CVGI
$72.5M
| $885K | 0.01% |
129,907
-2,659
| -2% | -$18.1K |
|
737
AnaptysBio
ANAB
$652M
| $882K | 0.01% |
28,465
-37,369
| -57% | -$1.16M |
|
738
Genuine Parts
GPC
$19.8B
| $877K | 0.01% |
+5,054
| New | +$877K |
|
739
ProAssurance
PRA
$1.22B
| $877K | 0.01% |
50,185
+23,454
| +88% | +$410K |
|
740
Tetra Tech
TTEK
$9.47B
| $874K | 0.01% |
+30,100
| New | +$874K |
|
|
JOYY
741
JOYY Inc. American Depositary Shares
JOYY
$3.17B
| $865K | 0.01% |
27,388
+1,823
| +7% | +$57.6K |
|
742
NMI Holdings
NMIH
$3.12B
| $863K | 0.01% |
41,303
+28,777
| +230% | +$601K |
|
743
Rigel Pharmaceuticals
RIGL
$671M
| $859K | ﹤0.01% |
+57,279
| New | +$859K |
|
744
Hilton Worldwide
HLT
$65.2B
| $859K | ﹤0.01% |
+6,797
| New | +$859K |
|
|
CPE
745
DELISTED
Callon Petroleum Company
CPE
| $856K | ﹤0.01% |
+23,089
| New | +$856K |
|
746
Verizon
VZ
$185B
| $854K | ﹤0.01% |
21,671
-299,605
| -93% | -$11.8M |
|
747
Precigen
PGEN
$1.23B
| $852K | ﹤0.01% |
560,617
+5,043
| +0.9% | +$7.67K |
|
748
Assertio
ASRT
$78M
| $842K | ﹤0.01% |
195,748
+941
| +0.5% | +$4.05K |
|
749
Kimbell Royalty Partners
KRP
$1.29B
| $836K | ﹤0.01% |
+50,071
| New | +$836K |
|
750
Y-mAbs Therapeutics
YMAB
$390M
| $834K | ﹤0.01% |
170,920
+127,068
| +290% | +$620K |
|